Resources

Publications

05/26/2023
- Oncology
Homologous Recombination Deficiency (HRD) in Non-Small Cell Lung Cancer: Genomic Analysis Using an RNA-Based HRD Algorithm
ASCO 2023
05/26/2023
- Oncology
Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer Populations
ASCO 2023
05/26/2023
- Oncology
Molecular Diagnostic Classification for Cancers of Unknown Primary (CUP): Post-Testing Diagnosis and Treatment Impact Analysis From Real-World Claims Data
ASCO 2023
05/26/2023
- Oncology
Real-World Outcomes of First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy in KRAS G12C Altered NSCLC According to PD-L1 Status
ASCO 2023
05/26/2023
- Oncology
Associations Between Androgen-Directed Treatments and AR Mutational Landscapes in the Circulating Tumor DNA of a Real-World Metastatic Prostate Cancer Cohort
ASCO 2023
05/26/2023
- Oncology
Germline Mutations and the Presence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in 20,963 Patients With BRCA-Associated Cancers
ASCO 2023
05/26/2023
- Oncology
Effect of Germline Mutations on Somatic Alteration Landscapes in BRCA-Associated Cancers
ASCO 2023
05/26/2023
- Oncology
Real-World Response Endpoints in Patients With mNSCLC Treated With Chemotherapy Across Real-World Datasets
ASCO 2023
05/26/2023
- Oncology
Evaluation of Microsatellite Instability Status, a Definitive Predictive Biomarker for Immune Checkpoint Inhibitors (ICI), in Underrepresented Minorities (URM) With Gastrointestinal (GI) Cancers
ASCO 2023
05/26/2023
- Oncology
The Tempus TIME Trial Portal and Clinical Trial Enrollment
ASCO 2023

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34